U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Fri Dec 15 17:32:53 GMT 2023
Edited
by admin
on Fri Dec 15 17:32:53 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
4F4X42SYQ6
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
RITUXIMAB
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IDEC-C 2B8
Code English
RITUXIMAB COMPONENT OF RITUXAN HYCELA
Brand Name English
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Common Name English
RITUXIMAB (GENETICAL RECOMBINATION)
JAN  
Official Name English
RITUXIMAB [HSDB]
Common Name English
Rituximab [WHO-DD]
Common Name English
RITUXIMAB [MART.]
Common Name English
RITUXIMAB [MI]
Common Name English
GP2013
Code English
IDEC-102
Code English
RITUXAN HYCELA COMPONENT RITUXIMAB
Brand Name English
RITUXIMAB [USAN]
Common Name English
RITUXIMAB [EMA EPAR]
Common Name English
USP MAB 001, MONOCLONAL IGG1 [USP-RS]
Common Name English
RITUXIMAB [VANDF]
Common Name English
rituximab [INN]
Common Name English
GP-2013
Code English
RITUXIMAB [JAN]
Common Name English
RITUXIMAB [PURPLE BOOK CDER]
Common Name English
IDEC102
Code English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 177603
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 923822
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
NDF-RT N0000175078
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 781520
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 465014
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 840621
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 542416
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
WHO-VATC QL01XC02
Created by admin on Fri Dec 15 17:32:54 GMT 2023 , Edited by admin on Fri Dec 15 17:32:54 GMT 2023
NCI_THESAURUS C129822
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
EMA ASSESSMENT REPORTS MABTHERA (AUTHORIZED: LYMPHOMA, NON-HODGKIN)
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 79793
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 546516
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
LIVERTOX NBK548249
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 922222
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 216305
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
NCI_THESAURUS C141215
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
NDF-RT N0000175657
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 155102
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 545616
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
WHO-ATC L01XC02
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
FDA ORPHAN DRUG 529816
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
EU-Orphan Drug EU/3/17/1869
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
Code System Code Type Description
IUPHAR
6780
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
MERCK INDEX
m9637
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY Merck Index
SMS_ID
100000089292
Created by admin on Fri Dec 15 17:32:54 GMT 2023 , Edited by admin on Fri Dec 15 17:32:54 GMT 2023
PRIMARY
DRUG BANK
DB00073
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
RXCUI
2273510
Created by admin on Fri Dec 15 17:32:54 GMT 2023 , Edited by admin on Fri Dec 15 17:32:54 GMT 2023
ALTERNATIVE
JAPANESE REVIEW
RITUXAN
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY APPROVED AUGUST 2014
DAILYMED
4F4X42SYQ6
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201576
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
WIKIPEDIA
RITUXIMAB
Created by admin on Fri Dec 15 17:32:54 GMT 2023 , Edited by admin on Fri Dec 15 17:32:54 GMT 2023
PRIMARY
USAN
II-64
Created by admin on Fri Dec 15 17:32:54 GMT 2023 , Edited by admin on Fri Dec 15 17:32:54 GMT 2023
PRIMARY
RS_ITEM_NUM
1445539
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
NCI_THESAURUS
C1702
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
INN
7609
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
CAS
174722-31-7
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
RXCUI
121191
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY RxNorm
EVMPD
SUB12570MIG
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
MESH
C092560
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
LACTMED
Rituximab
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID5040910
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
FDA UNII
4F4X42SYQ6
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
RXCUI
2105824
Created by admin on Fri Dec 15 17:32:54 GMT 2023 , Edited by admin on Fri Dec 15 17:32:54 GMT 2023
ALTERNATIVE
DRUG CENTRAL
4975
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
JAPANESE REVIEW
ROMIPLATE
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY APPROVED JANUARY 2011
HSDB
7455
Created by admin on Fri Dec 15 17:32:53 GMT 2023 , Edited by admin on Fri Dec 15 17:32:53 GMT 2023
PRIMARY
From To
1_22 1_96
1_148 1_204
1_265 1_325
1_371 1_429
3_23 3_87
3_133 4_193
2_224 3_213
2_22 2_96
2_148 2_204
2_265 2_325
2_371 2_429
3_23 3_87
3_133 4_193
2_224 3_213
1_230 2_230
1_233 2_233
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_301
N 2_301
Related Record Type Details
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
BIOSIMILAR -> PARENT
LABELED -> NON-LABELED
SUB_CONCEPT->SUBSTANCE
TARGET -> SUBSTRATE
TARGET->LIGAND
BINDING
TARGET -> AGONIST
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL